Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant Recruiting Phase 2 Trials for Avelumab (DB11945)

IndicationStatusPhase
DBCOND0115402 (Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03744793Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial CancerTreatment